Skip to content
SAMDI Tech
Better. Faster. Label-Free.
  • Why Label-Free Assays
  • Drug Discovery Solutions
    • Overview
    • Assay Development
    • High-Throughput Screening
    • SAMDI ASMS Technology
    • Small Molecule Compound Libraries
    • Substrate Specificity Profiling
    • Beyond Label-Free
      • Optical Assay Solutions
      • Radioactivity Assay Solutions
  • Scientific Resources
  • About Us
    • About Us
    • Executive Leadership
    • Board of Directors
    • Strategic Partnerships
    • Recognition and Awards
    • News
    • Events
    • Careers
  • Contact Us
  • Careers
  • Search

SAMDI Mass Spectrometry

  • Why Label-Free Assays
  • Drug Discovery Solutions
    • Overview
    • Assay Development
    • High-Throughput Screening
    • SAMDI ASMS Technology
    • Small Molecule Compound Libraries
    • Substrate Specificity Profiling
    • Beyond Label-Free
      • Optical Assay Solutions
      • Radioactivity Assay Solutions
  • Scientific Resources
  • About Us
    • About Us
    • Executive Leadership
    • Board of Directors
    • Strategic Partnerships
    • Recognition and Awards
    • News
    • Events
    • Careers
  • Contact Us

Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-19 pandemic that began in 2019. The…

Ultra High-Throughput Affinity Selection Mass Spectrometry Assays

A Mass Spectrometric Assay of METTL3/ METTL14 Methyltransferase Activity

Abstract A variety of covalent modifications of RNA have been identified and demonstrated to affect RNA processing, stability, and translation….

Accelerating Drug Discovery from Protein to Cells with Ultra High-Throughput SAMDI Mass Spectrometry

The Fast and Victorious: Level Up Your Drug Discovery With Innovative Mass Spectrometry

An Enabling Label-Free Platform for RNA Drug Discovery Using SAMDI Mass Spectrometry

Mass Spectrometry Gaining Momentum for Biochemical Assay Development and Screening

The goal of drug discovery is clear: reveal chemical matter that generates the most effective response towards a particular target…

Application of MALDI-MS for HTS and SAR

Disrupting Drug Discovery Research From Assay Development to Lead Compound

High-throughput screening remains one of the most powerful, unbiased approaches for small molecule drug discovery. Today, the toolbox for high-throughput…

A Mass Spectrometric Assay for METTL3/14 Methyltransferase Activity

Posts navigation

Older posts
  • Privacy Policy
  • Contact Us

SAMDI Tech, Inc.
3440 South Dearborn Street
Suite 220S
Chicago, IL 60616

Phone: 312.235.3575

© 2021 SAMDI Tech, Inc. All rights reserved.

Connect with us on
  • Why Label-Free Assays
  • Drug Discovery Solutions
    • Overview
    • Assay Development
    • High-Throughput Screening
    • SAMDI ASMS Technology
    • Small Molecule Compound Libraries
    • Substrate Specificity Profiling
    • Beyond Label-Free
      • Optical Assay Solutions
      • Radioactivity Assay Solutions
  • Scientific Resources
  • About Us
    • About Us
    • Executive Leadership
    • Board of Directors
    • Strategic Partnerships
    • Recognition and Awards
    • News
    • Events
    • Careers
  • Contact Us
  • Careers
  • Search